CIK 0000882095
- Large accelerated filer
GILEAD SCIENCES, INC.
Sign in to watch- Ticker
- GILD
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 943047598
- Phone
- +1 650-574-3000
- Business address
- 333 LAKESIDE DR, FOSTER CITY, CA, 94404
- Former names
- GILEAD SCIENCES INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $36,996,096
- in 12 filings, $37.0M under 10b5-1 plans
Net −$36,996,096. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2023-03-10 | O'Day Daniel Patrick Chairman & CEO | Option exercise | +10,800 | 389,783 | ||
| 2023-03-10 | O'Day Daniel Patrick Chairman & CEO | Shares withheld for taxes | −14,017 | $79.50 | $1.1M | 375,766 |
| 2023-03-10 | O'Day Daniel Patrick Chairman & CEO | Option exercise · Restricted Stock Unit | −19,488 | 96,563 | ||
| 2023-03-10 | O'Day Daniel Patrick Chairman & CEO | Option exercise · Restricted Stock Unit | −10,800 | 85,763 | ||
| 2023-03-10 | O'Day Daniel Patrick Chairman & CEO | Grant or award · Restricted Stock Unit | +47,170 | 132,933 | ||
| 2023-03-10 | O'Day Daniel Patrick Chairman & CEO | Grant or award · Non-qualified Stock Option (Right to Buy) | +215,095 | 215,095 | ||
| 2023-03-10 | Parsey Merdad Chief Medical Officer | Option exercise | +3,455 | 73,585 | ||
| 2023-03-10 | Parsey Merdad Chief Medical Officer | Option exercise | +7,999 | 81,584 | ||
| 2023-03-10 | Parsey Merdad Chief Medical Officer | Shares withheld for taxes | −5,328 | $79.50 | $424K | 76,256 |
| 2023-03-10 | Parsey Merdad Chief Medical Officer | Option exercise · Restricted Stock Unit | −3,455 | 40,646 | ||
| 2023-03-10 | Parsey Merdad Chief Medical Officer | Option exercise · Restricted Stock Unit | −7,999 | 32,647 | ||
| 2023-03-10 | Parsey Merdad Chief Medical Officer | Grant or award · Restricted Stock Unit | +16,665 | 49,312 | ||
| 2023-03-10 | Parsey Merdad Chief Medical Officer | Grant or award · Non-qualified Stock Option (Right to Buy) | +76,000 | 76,000 | ||
| 2023-03-10 | Patterson Sandra SVP, Controllership | Option exercise | +1,601 | 25,693 | ||
| 2023-03-10 | Patterson Sandra SVP, Controllership | Option exercise | +1,320 | 27,013 | ||
| 2023-03-10 | Patterson Sandra SVP, Controllership | Shares withheld for taxes | −801 | $79.50 | $64K | 26,212 |
| 2023-03-10 | Patterson Sandra SVP, Controllership | Option exercise · Restricted Stock Unit | −1,601 | 17,748 | ||
| 2023-03-10 | Patterson Sandra SVP, Controllership | Option exercise · Restricted Stock Unit | −1,320 | 16,428 | ||
| 2023-03-10 | Patterson Sandra SVP, Controllership | Grant or award · Restricted Stock Unit | +6,130 | 22,558 | ||
| 2023-03-10 | Patterson Sandra SVP, Controllership | Grant or award · Non-qualified Stock Option (Right to Buy) | +10,405 | 10,405 |
Page 36 of 43 · 851 trades